Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 10, 2012, Pages 2108-2115

  Mutch, N J ^a   Waters, E K ^b   Morrissey, J H ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Coagulation; Contact pathway; Factor XI; Factor XII; Metal ions; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; CHELATING AGENT; COBALT; CUPRIC ION; DEXTRAN SULFATE; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; LIPID; LIPOSOME; NICKEL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PREKALLIKREIN; TRANSITION ELEMENT; ZINC ION;

ADSORPTION; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING; CONTROLLED STUDY; IMMOBILIZATION; PARTIAL THROMBOPLASTIN TIME; PHOSPHOLIPID BILAYER; PLASMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ADSORPTION; BINDING SITES; BLOOD COAGULATION; CHELATING AGENTS; COBALT; COPPER; ENZYME ACTIVATION; FACTOR XI; FACTOR XII; FACTOR XIIA; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; LIPOSOMES; LYSINE; NICKEL; OLEIC ACIDS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SUCCINATES; SURFACE PLASMON RESONANCE; TIME FACTORS; ZINC;

EID: 84866874935     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04890.x     Document Type: Article

References (43)

1. Revak SD, Cochrane CG, Griffin JH. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. J Clin Invest 1977; 59: 1167-75.
2. Griffin JH. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci USA 1978; 75: 1998-2002.
3. Tans G, Rosing J, Griffin JH. Sulfatide-dependent autoactivation of human blood coagulation factor XII (Hageman factor). J Biol Chem 1983; 258: 8215-22.
4. Rojkjaer R, Schousboe I. The surface-dependent autoactivation mechanism of factor XII. Eur J Biochem 1997; 243: 160-6.
5. Schousboe I. Inositolphospholipid-accelerated activation of prekallikrein by activated factor XII and its inhibition by beta 2-glycoprotein I. Eur J Biochem 1988; 176: 629-36.
6. Tankersley DL, Finlayson JS. Kinetics of activation and autoactivation of human factor XII. Biochemistry 1984; 23: 273-9.
7. Tans G, Rosing J, Berrettini M, Lammle B, Griffin JH. Autoactivation of human plasma prekallikrein. J Biol Chem 1987; 262: 11308-14.
8. Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl ML, Sedding D, Massberg S, Gunther A, Engelmann B, Preissner KT. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388-93.
9. van der Meijden PE, Munnix IC, Auger JM, Govers-Riemslag JW, Cosemans JM, Kuijpers MJ, Spronk HM, Watson SP, Renne T, Heemskerk JW. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114: 881-90.
10. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-8.
11. Muller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renne T. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139: 1143-56.
12. Motta G, Rojkjaer R, Hasan AA, Cines DB, Schmaier AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 1998; 91: 516-28.
13. Shore JD, Day DE, Bock PE, Olson ST. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions. Biochemistry 1987; 26: 2250-8.
14. Shimada T, Kato H, Iwanaga S. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein. J Biochem 1987; 102: 913-21.
15. Greengard JS, Griffin JH. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 1984; 23: 6863-9.
16. Bernardo MM, Day DE, Halvorson HR, Olson ST, Shore JD. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. J Biol Chem 1993; 268: 12477-83.
17. Herwald H, Morgelin M, Svensson HG, Sjobring U. Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur J Biochem 2001; 268: 396-404.
18. Bock PE, Srinivasan KR, Shore JD. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Biochemistry 1981; 20: 7258-66.
19. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 1995; 34: 13988-93.
20. Smith SA, Morrissey JH. Rapid and efficient incorporation of tissue factor into liposomes. J Thromb Haemost 2004; 2: 1155-62.
21. Waters EK, Morrissey JH. Restoring full biological activity to the isolated ectodomain of an integral membrane protein. Biochemistry 2006; 45: 3769-74.
22. Mutch NJ, Myles T, Leung LL, Morrissey JH. Polyphosphate binds with high affinity to exosite II of thrombin. J Thromb Haemost 2010; 8: 548-55.
23. Darst SA. A new twist on protein crystallization. Proc Natl Acad Sci USA 1998; 95: 7848-9.
24. Herwald H, Morgelin M, Bjorck L. Contact activation by pathogenic bacteria: a virulence mechanism contributing to the pathophysiology of sepsis. Scand J Infect Dis 2003; 35: 604-7.
25. Herwald H, Morgelin M, Olsen A, Rhen M, Dahlback B, Muller-Esterl W, Bjorck L. Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med 1998; 4: 298-302.
26. Colman RW. The contact system: a proinflammatory pathway with antithrombotic activity. Nat Med 1998; 4: 277-8.
27. Battistoni A. Role of prokaryotic Cu, Zn superoxide dismutase in pathogenesis. Biochem Soc Trans 2003; 31: 1326-9.
28. Krishnakumar R, Craig M, Imlay JA, Slauch JM. Differences in enzymatic properties allow SodCI but not SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium strain 14028. J Bacteriol 2004; 186: 5230-8.
29. D'Orazio M, Folcarelli S, Mariani F, Colizzi V, Rotilio G, Battistoni A. Lipid modification of the Cu, Zn superoxide dismutase from Mycobacterium tuberculosis. Biochem J 2001; 359: 17-22.
30. Steinman HM. Bacteriocuprein superoxide dismutase of Photobacterium leiognathi. Isolation and sequence of the gene and evidence for a precursor form. J Biol Chem 1987; 262: 1882-7.
31. Mobley HLT. Urease. In: Mobley H, Mendz G, Hazell S, eds. Helicobacter pylori: Physiology and Genetics. Washington, D.C: ASM Press, 2001: 179-91.
32. Follmer C, Barcellos GB, Zingali RB, Machado OL, Alves EW, Barja-Fidalgo C, Guimaraes JA, Carlini CR. Canatoxin, a toxic protein from jack beans (Canavalia ensiformis), is a variant form of urease (EC 3.5.1.5): biological effects of urease independent of its ureolytic activity. Biochem J 2001; 360: 217-24.
33. Follmer C, Real-Guerra R, Wasserman GE, Olivera-Severo D, Carlini CR. Jackbean, soybean and Bacillus pasteurii ureases: biological effects unrelated to ureolytic activity. Eur J Biochem 2004; 271: 1357-63.
34. Carlini CR, Guimaraes JA, Ribeiro JM. Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway. Br J Pharmacol 1985; 84: 551-60.
35. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD, American Heart Association Council on Epidemiology Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity, Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010; 121: 2331-78.
36. Mateen FJ, Brook RD. Air pollution as an emerging global risk factor for stroke. JAMA 2011; 305: 1240-1.
37. Kilinc E, van Oerle R, Borissoff JI, Oschatz C, Gerlofs-Nijland ME, Janssen NA, Cassee FR, Sandstrom T, Renne T, Ten Cate H, Spronk HM. Factor XII activation is essential to sustain the procoagulant effects of particulate matter. J Thromb Haemost 2011; 9: 1359-67.
38. Ripanucci G, Grana M, Vicentini L, Magrini A, Bergamaschi A. Dust in the underground railway tunnels of an Italian town. J Occup Environ Hyg 2006; 3: 16-25.
39. Seaton A, Cherrie J, Dennekamp M, Donaldson K, Hurley JF, Tran CL. The London Underground: dust and hazards to health. Occup Environ Med 2005; 62: 355-62.
40. Moreno T, Querol X, Alastuey A, de la Rosa J, Sanchez de la Campa AM, Minguillon M, Pandolfi M, Gonzalez-Castanedo Y, Monfort E, Gibbons W. Variations in vanadium, nickel and lanthanoid element concentrations in urban air. Sci Total Environ 2010; 408: 4569-79.
41. Cao J, Xu H, Xu Q, Chen B, Kan H. Fine particulate matter constituents and cardiopulmonary mortality in a heavily polluted Chinese city. Environ Health Perspect 2012; 120: 373-8.
42. Zhang Z, Chau PY, Lai HK, Wong CM. A review of effects of particulate matter-associated nickel and vanadium species on cardiovascular and respiratory systems. Int J Environ Health Res 2009; 19: 175-85.
43. Wallenborn JG, McGee JK, Schladweiler MC, Ledbetter AD, Kodavanti UP. Systemic translocation of particulate matter-associated metals following a single intratracheal instillation in rats. Toxicol Sci 2007; 98: 231-9.